[Hiring] Senior Market Access Analyst II @Glaukos

Role Description

Join a growing Market Access team where you'll help shape pricing, reimbursement, contracting, and channel strategy through advanced analytics and strategic insights. This highly visible role partners closely with senior leadership to drive data-informed decisions that improve patient access and support long-term commercial success.

• Lead enterprise-wide market access analytics across pricing, contracting, reimbursement, and channel strategy.
• Develop scenario models and business impact assessments to support strategic decision-making.
• Provide executive-level insights on access performance, risks, and opportunities.
• Define and track key performance indicators related to payer access, reimbursement, and patient journey performance.
• Lead analytics supporting Buy and Bill and Specialty Pharmacy channel optimization.
• Analyze HUB, payer, and field reimbursement data to identify trends and access barriers.
• Build scalable reporting, analytics, and data governance capabilities across multiple data sources.
• Partner cross-functionally with Commercial, Market Access, Finance, Patient Services, and other stakeholders to support strategic planning and business growth.

Qualifications

• Bachelor's degree required; advanced degree preferred.
• 8+ years of experience in market access analytics, pricing, reimbursement, HEOR, or related healthcare analytics functions.
• Deep understanding of payer dynamics, reimbursement, and channel strategy.
• Experience influencing senior leaders through data-driven recommendations.
• Strong analytical, modeling, and problem-solving skills.
• Proven ability to build and scale analytics capabilities that drive business impact.

Company Description

Founded in 1998, Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.

• Our mission at Glaukos is to truly transform vision by pioneering novel, dropless therapies that can meaningfully advance the standard of care and improve the lives of patients suffering from chronic, sight-threatening eye diseases.
• Innovation is at the core of everything we do, and we are resolute in our commitment to challenge conventional thinking with new treatment alternatives that are supported by real science, robust clinical evidence, and an unrelenting focus on patients.
• Our constant pursuit of game-changing technologies that disrupt legacy treatment paradigms is encapsulated in the Glaukos mantra “We’ll Go First.”
• Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol “GKOS.”
• Our global headquarters is in Aliso Viejo, California with additional locations in San Clemente, California, and Burlington, Massachusetts.